Allergan Can't Duck Class Action Over Cream Cancer Risks
A California federal judge on Friday refused to throw out a proposed class action claiming an Allergan Inc. subsidiary concealed from consumers that its anti-aging creams derived from human foreskin cells...To view the full article, register now.
Already a subscriber? Click here to view full article